Unique ID issued by UMIN | UMIN000000874 |
---|---|
Receipt number | R000001027 |
Scientific Title | A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703) |
Date of disclosure of the study information | 2007/11/01 |
Last modified on | 2014/04/30 11:59:11 |
A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703)
A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703)
A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703)
A phase II study of laparoscopy assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG0703)
Japan |
clinical stage I gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the safety of laparoscopy assisted distal gastrectomy (LADG) with nodal dissection for clinical stage IA or IB gastric cancer.
Safety
Exploratory
Phase II
Incidence of anastomotic leakage or pancreatic fistula
overall survival, recurrence-free survival, proportion of LADG completion, proportion of conversion to open surgery, adverse events, short-term clinical outcomes
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Laparoscopy assisted distal gastrectomy
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) Histologically proven gastric adenocarcinoma.
2) cStage IA or IB.
3) No indication of endoscopic mucosal resection (EMR) in a cN0 case.
4) Tumor located in the middle or lower 1/3 of the stomach and indication for distal gastrectomy.
5) No invasion to duodenum.
6) Aged 20 to 80 year.
7) PS (ECOG) of 0 or 1.
8) Body mass index <30.
9) Not recurrence after EMR.
10) No history of upper abdominal surgery and no history of intestinal resection.
11) No prior treatment of chemotherapy or radiation therapy against any other malignancies.
12) Sufficient organ functions.
13) Written informed consent.
1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
2) Women during pregnancy or breast-feeding.
3) Severe mental disease.
4) Continuous systemic steroid therapy.
5) History of myocardial infarction or unstable angina pectoris within six months.
6) Uncontrollable hypertension.
7) Uncontrollable diabetes millutus or administration of insulin.
8) Severe respiratory disease requiring continuous oxygen therapy.
170
1st name | |
Middle name | |
Last name | Hitoshi Katai |
National Cancer Center Hospital
Division of Gastric Surgery
5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, JAPAN
03-3542-2511
1st name | |
Middle name | |
Last name | Hitoshi Katai |
JCOG0703 Coordinating Office
Division of Gastric Surgery, National Cancer Center Hospital
5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, JAPAN
03-3542-2511
http://www.jcog.jp/
JCOG_sir@ml.jcog.jp
Japan Clinical Oncology Group(JCOG)
Ministry of Health, Labour and Welfare
Japan
NO
国立病院機構仙台医療センター(宮城県)
山形県立中央病院(山形県)
国立がんセンター中央病院(東京都)
東京医科歯科大学(東京都)
癌研究会有明病院(東京都)
都立墨東病院(東京都)
神奈川県立がんセンター(神奈川県)
静岡県立総合病院(静岡県)
愛知県がんセンター中央病院(愛知県)
藤田保健衛生大学(愛知県)
近畿大学医学部(大阪府)
大阪府立病院機構大阪府立成人病センター(大阪府)
大阪医科大学(大阪府)
和歌山県立医科大学(和歌山県)
広島市立広島市民病院(広島県)
大分大学医学部附属病院(大分県)
2007 | Year | 11 | Month | 01 | Day |
Published
http://www.ncbi.nlm.nih.gov/pubmed/21128059
See the datails via "URL releasing results" above.
Also the details can be seen in the JCOG website:
http://www.jcog.jp/en/trials/index.html
Main results already published
2007 | Year | 09 | Month | 13 | Day |
2007 | Year | 09 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2007 | Year | 11 | Month | 01 | Day |
2014 | Year | 04 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001027